Leigh syndrome T8993C mitochondrial DNA mutation: Heteroplasmy and the first clinical presentation in a Vietnamese family

Weerasinghe,Chamara Arachchighe Lahiru; Bui,Bich‑Hong Thi; Vu,Thu Thi; Nguyen,Hong‑Loan Thi; Phung,Bao‑Khanh; Nguyen,Van‑Minh; Pham,Van‑Anh; Cao,Vu‑Hung; Phan,Tuan‑Nghia

doi:10.3892/mmr.2018.8670

Leigh syndrome T8993C mitochondrial DNA mutation: Heteroplasmy and the first clinical presentation in a Vietnamese family

Authors:
- Chamara Arachchighe Lahiru Weerasinghe
- Bich‑Hong Thi Bui
- Thu Thi Vu
- Hong‑Loan Thi Nguyen
- Bao‑Khanh Phung
- Van‑Minh Nguyen
- Van‑Anh Pham
- Vu‑Hung Cao
- Tuan‑Nghia Phan
View Affiliations

Affiliations: Key Laboratory of Enzyme and Protein Technology, VNU University of Science, Hanoi 100000, Vietnam, Department of Neurology, Vietnam National Children's Hospital, Hanoi 100000, Vietnam
Published online on: March 1, 2018 https://doi.org/10.3892/mmr.2018.8670
Pages: 6919-6925

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Leigh syndrome is a rare inherited, heterogeneous and progressive neurometabolic disorder that is mainly caused by specific mutations in nuclear DNA (nDNA) or mitochondrial DNA (mtDNA). The present study reported a case of childhood Leigh syndrome with a point mutation at bp 8,993 in the mitochondrial ATPase6 gene. A 21‑month‑old male child had developed epilepsy, muscular weakness and vomiting, which was accompanied by high fever. Magnetic resonance imaging indicated typical characteristics of Leigh syndrome, including a symmetric abnormal signal in the dorsal medulla oblongata and Sylvian fissure enlargement in association with an abnormal signal in the periventricular white matter and in the putamina and caudate heads. The diagnosis was further supported with genetic tests including polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), sequencing, and quantitative PCR. The patient was found to carry a mitochondrial T8993C (m.T8993C) mutation in peripheral blood with 94.00±1.34% heteroplasmy. Eight of his relatives were also subjected to quantification of the m.T8993C mutation. The percentages of heteroplasmy in samples taken from the grandmother, mother, aunt, cousin 1, and cousin 2 were 16.33±1.67, 66.81±0.85, 71.66±3.22, 87.00±1.79, and 91.24±2.50%, respectively. The mutation was not found in samples taken from the father, the husband of the aunt, or the grandfather of the patient. The obtained data showed that the mutation was maternally inherited and accumulated through generations. Even though the heteroplasmy levels of his mother, aunt, cousin 1, and cousin 2 were relatively high (66.81‑91.24%), they remained asymptomatic, indicating that the threshold at which this mutation shows effects is high. To the best of our knowledge, this is the first report of a case of Leigh syndrome in a Vietnamese individual harboring a mtDNA mutation at the 8,993 bp site, and showing a correlation between the heteroplasmy and clinical phenotype. These findings may be useful in helping to improve the clinical diagnosis and treatment of Leigh syndrome.

View Figures

View References

1	Leigh PN, Al-Sarraj S and DiMauro S: Impact commentaries. Subacute necrotising encephalomyelopathy (Leigh's disease; Leigh syndrome). J Neurol Neurosurg Psychiatry. 86:363–365. 2015. View Article : Google Scholar : PubMed/NCBI
2	Piao YS, Tang GC, Yang H and Lu DH: Clinico-neuropathological study of a Chinese case of familial adult Leigh syndrome. Neuropathology. 26:218–221. 2006. View Article : Google Scholar : PubMed/NCBI
3	Finsterer J: Leigh and leigh-like syndrome in children and adults. Pediatr Neurol. 39:223–235. 2008. View Article : Google Scholar : PubMed/NCBI
4	Thorburn DR, Rahman J and Rahman S: Mitochondrial DNA-associated Leigh syndrome and NARPAdam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K and Amemiya A: Source GeneReviews^® [Internet]. University of Washington; Seattle, WA: pp. 1993–2018
5	Piekutowska-Abramczuk D: The molecular background of Leigh syndrome. Neurol Neurochir Pol. 42:238–250. 2008.(In Polish). PubMed/NCBI
6	White SL, Shanske S, McGill JJ, Mountain H, Geraghty MT, DiMauro S, Dahl HH and Thorburn DR: Mitochondrial DNA mutations at nucleotide 8993 show a lack of tissue- or age-related variation. J Inherit Metab Dis. 22:899–914. 1999. View Article : Google Scholar : PubMed/NCBI
7	Bonfante E, Koenig MK, Adejumo RB, Perinjelil V and Riascos RF: The neuroimaging of Leigh syndrome: Case series and review of the literature. Pediatr Radiol. 46:443–451. 2016. View Article : Google Scholar : PubMed/NCBI
8	Santorelli FM, Shanske S, Macaya A, DeVivo DC and DiMauro S: The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol. 34:827–834. 1993. View Article : Google Scholar : PubMed/NCBI
9	Makino M, Horai S, Goto Y and Nonaka I: Mitochondrial DNA mutations in Leigh syndrome and their phylogenetic implications. J Hum Genet. 45:69–75. 2000. View Article : Google Scholar : PubMed/NCBI
10	Santorelli FM, Shanske S, Jain KD, Tick D, Schon EA and DiMauro S: A T->C mutation at nt 8993 of mitochondrial DNA in a child with Leigh syndrome. Neurology. 44:972–974. 1994. View Article : Google Scholar : PubMed/NCBI
11	Morava E, Rodenburg RJ, Hol F, de Vries M, Janssen A, van den Heuvel L, Nijtmans L and Smeitink J: Clinical and biochemical characteristics in patients with a high mutant load of the mitochondrial T8993G/C mutations. Am J Med Genet A. 140A:863–868. 2006. View Article : Google Scholar
12	Tatuch Y, Pagon RA, Vlcek B, Roberts R, Korson M and Robinson BH: The 8993 mtDNA mutation: Heteroplasmy and clinical presentation in three families. Eur J Hum Genet. 2:35–43. 1994. View Article : Google Scholar : PubMed/NCBI
13	Baracca A, Sgarbi G, Mattiazzi M, Casalena G, Pagnotta E, Valentino ML, Moggio M, Lenaz G, Carelli V and Solaini G: Biochemical phenotypes associated with the mitochondrial ATP6 gene mutations at nt8993. Biochim Biophys Acta. 1767:913–919. 2007. View Article : Google Scholar : PubMed/NCBI
14	Huntsman RJ, Sinclair DB, Bhargava R and Chan A: Atypical presentations of Leigh syndrome: A case series and review. Pediatr Radiol. 32:334–340. 2004.
15	Bakshi R, Ariyaratana S, Benedict RH and Jacobs L: Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. Arch Neurol. 58:742–748. 2001. View Article : Google Scholar : PubMed/NCBI
16	Truong HT, Nguyen TVA, Nguyen LV, Pham VA and Phan TN: Screening of common point-mutations and discovery of new T14727C change in mitochondrial genome of Vietnamese encephalomyopathy patients. Mitochondrial DNA A DNA Mapp Seq Anal. 27:441–448. 2016. View Article : Google Scholar : PubMed/NCBI
17	Truong HT, Nguyen TVA, Nguyen THL, Pham VA and Phan TN: Sensitive quantification of mitochondrial mutation using new Taqman probes. Cent Eur J Med. 9:839–848. 2014.
18	Kumagai R, Ichikawa K, Yasui T, Kageyama Y and Miyabayashi S: Adult Leigh syndrome: Treatment with intravenous soybean oil for acute central respiratory failure. Eur J Neurol. 6:613–615. 1999. View Article : Google Scholar : PubMed/NCBI
19	Ruhoy IS and Saneto RP: The genetics of Leigh syndrome and its implications for clinical practice and risk management. Appl Clin Genet. 7:221–234. 2014.PubMed/NCBI
20	Makino M, Horai S, Goto Y and Nonaka I: Confirmation that a T-to-C mutation at 9176 in mitochondrial DNA is an additional candidate mutation for Leigh's syndrome. Neuromuscul Disord. 8:149–151. 1998. View Article : Google Scholar : PubMed/NCBI
21	Enns GM, Bai RK, Beck AE and Wong LJ: Clinical correlations in a family with variable tissue mitochondrial DNA T8993G mutant load. Mol Genet Metab. 88:364–371. 2006. View Article : Google Scholar : PubMed/NCBI
22	Debray FG, Lambert M, Lortie A, Vanasse M and Mitchell GA: Long-term outcome of Leigh syndrome caused by the NARP-T8993C mtDNA mutation. Am J Med Genet A. 143A:2046–2051. 2007. View Article : Google Scholar : PubMed/NCBI
23	Fujii T, Hattori H, Higuchi Y and Tsuji M: Phenotypic differences between T->C and T->G mutations at nt 8993 of mitochondrial DNA in Leigh syndrome. Pediatr Neurol. 18:275–277. 1998. View Article : Google Scholar : PubMed/NCBI
24	Pallotti F, Baracca A, Hernandez-Rosa E, Walker WF, Solaini G, Lenaz G, Melzi D'Eril GV, Dimauro S, Schon EA and Davidson MM: Biochemical analysis of respiratory function in cybrid cell lines harbouring mitochondrial DNA mutations. Biochem J. 384:287–293. 2004. View Article : Google Scholar : PubMed/NCBI
25	Baracca A, Barogi S, Carelli V, Lenaz G and Solaini G: Catalytic activities of mitochondrial ATP synthase in patients with mitochondrial DNA T8993G mutation in the ATPase 6 gene encoding subunit a. J Biol Chem. 275:4177–4182. 2000. View Article : Google Scholar : PubMed/NCBI
26	Dahl HH, Thorburn DR and White SL: Towards reliable prenatal diagnosis of mtDNA point mutations: Studies of nt8993 mutations in oocytes, fetal tissues, children and adults. Hum Reprod. 15 Suppl 2:S246–S255. 2000. View Article : Google Scholar
27	St John JC, Facucho-Oliveira J, Jiang Y, Kelly R and Salah R: Mitochondrial DNA transmission, replication and inheritance: A journey from the gamete through the embryo and into offspring and embryonic stem cells. Hum Reprod Update. 16:488–509. 2010. View Article : Google Scholar : PubMed/NCBI